NYSE:KAPA | Insider Transactions | Kairos Pharma, LTD.

KAPA Insider Transactions

3 retained open-market purchase and sale rows from SEC Forms 3, 4 and 5, newest first. This page shows rows 1–3; provenance stays internal.

KAPA insiders transaction timeline

PurchaseSale
2024-11-20: 1 purchase — Yu John S2024-11-22: 1 purchase — Samuelson Doug2024-11-25: 1 purchase — Murali Ramachandran2024-11-202024-11-25
Insider profileRoleDateTransactionSharesPrice
Murali RamachandranVP of Research and Development2024-11-25Purchase200.0$1.59
Samuelson DougChief Financial Officer2024-11-22Purchase2,500.0$1.5
Yu John SCEO and Chairman2024-11-20Purchase4,000.0$1.44